Skip to content

Detection of expression levels of relevant indicators in scarred skin tissue

Detection of expression levels of relevant indicators in scarred skin tissue

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119712
Enrollment
Unknown
Registered
2026-03-03
Start date
2026-03-03
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin scars

Interventions

Observation group:N/A

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 65, of either gender, who plan to undergo scar excision surgery. The scar formation duration exceeds 6 months and is in a stable phase.

Exclusion criteria

Exclusion criteria: Women who are pregnant or breastfeeding. Those with systemic diseases that affect wound healing (such as uncontrolled diabetes, autoimmune diseases, severe malnutrition, etc.). Scars with active infection, ulceration, or malignancy. Long-term use of drugs that may affect fibrosis (such as systemic glucocorticoids, immunosuppressants, etc.). Scars with a history of radiation therapy. Any other conditions that the investigator deems unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
YAP expression level;PYCR1 expression level;a-SMA expression level;

Secondary

MeasureTime frame
CSF1R expression level;CSF1 expression level;

Countries

China

Contacts

Public ContactZongguang Tai

Shanghai Skin Disease Hospital

taizongguang@126.com+86 186 2119 7993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026